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Of the many triumphs in our fight against cancer. perhaps the best
recognized has been the significant decrease in cervical cancer
incidence worldwide through the use of the Papanicolau (Pap)
screening test, As with many other public health successes, routine
cytological screening and treatment of dysplasia and carcinoma in
situ were performed without complete knowledge of the cause(s) or
natural history of cervical malignanc\ Our understanding of cervi
cal neoplasia and the carcinogenic proce’s has come a long way
since the introduction of the Pap smear, and we now know that the
maioritv of cervical cancer is caused by a single infectious agent. the
human papillomavirus (HPV). What we dont know is why only
certain women develop cervical dvsplasia or cervical cancer when
HPV infection appears relatively common; nor why Asian/Pacific
Islanders in Hawaii generally have lower incidence rates of HPV
associated squamous cell carcinomas than whites.1
In 1991. prompted h\ the availability of a new DNA amplifying
technique. polymerasc chain reaction (PCR. we initiated a case—
control stud of risk factors for pre—malignant changes in cervical
epithelium. The specific aims of this five-year in estigation. funded
by the National Cancer Institute, were to identify viral and non-viral
risk factors for cervical dysplasia. with a special emphasis on the
interaction of KPV and diet, Eligible subjects included non-hyster
ectomized women, froni I $ to 84 years of age. v ho were residents
of Honolulu. Vvomen ‘ ho had been pregnant or lactating within 6
nionthsofenrollment. who had adiagnosis o1’cervical abnormalities
with in the past three ears, or ho were cliii ic referrals crc
considered ineligible forstudv. Eligible cases were identified through
the cytology logs of the participating clinics and included all omen
with a c tological classification of atypical squamous cells of
undetermined significance (ASCIJS) or squamous intraepithelial
lesion (SILt according to the Bethesda system. Potentially eligible
women were contacted b\ letter. follo ed by a telephone call, for
consent to participate m the studs before their return to the clinic for
a fullow—up examination and cervical smear. A. part of the stnd . a
colposcop v as pcrtormcd and cervical cells e crc collected for
H PV testing. Interview information as obtained from 214 ss omen
with biopsy-confirmed SIL and 254 women \v ith a cytological
diagnosis of ASCUS. Blood was drawn from 147 of the S1L cases
and 185 of’ the ASCUS cases who completed interviews,
Controls were women vs ith negati\ e cytological smears attending
the same clinics as the cases. Eligible women were selected from the
admission logs of the participating clinics on a randomly selected
day of the month. Potential controls were met at the clinics by one
of the interviewers who explained the purpose of the study, An
exfoliated cervical cell specimen was obtained at the time of the
cervical cytological smear. Of the 271 women with negative cyto
logical results who were inters iewed, 191 further consented to have
their blood drawn.
Participants vs crc scheduled for a personal interview at their
homes or other convenient location. A standardized questionnaire
was used to elicit a detailed sexual and reproductive history. inc hid
ing age at first intercourse, number of sexual partners and methods
of contraception. diet, a lifetime history of tobacco and alcohol use.
and other demographic and lifestyle information. Fasting blood was
used to determine plasma levels of a variet of nutrients. DNA was
purified from peripheral blood leukoc tes by SDS/proteinase K
treatment and phenol/chloroform extraction for genetic analvsi.
Frozen cervical cell specimens vs crc prepared for FIPV-DNA detec
tion h PCR amplification and dot blothvbridization of the amplicons.
Our l’indings suggest that high plasma concentrations of several
antioxidants ma\ reduce the risk of ASCI1 and cervical SIL.5 We
found an inverse dose-response of a-cryptoxanthin, total toco
pherol. and a-tocopherol to the odds ratios for cervical SIL, after
adjustment for HPV. tobacco smoking. and alcohol drinking. The
risk of cervical dvsplasia was reduced by about 70’i among women
in the highest compared with the lovvest quartile of these micronu
trients. We were also interested in the influence of dietary and
plasma folate levels and related compounds on the risk of cers ical
dysplasia. Folate is essential to the synthesis of nucleotides, and loss
levels of folate have implications for cell replication, DNA excision
and repair, and DNA hypomeihylation. We found an inverse asso
ciation of dietary. hut not plasma.7levels of folate. vitamin B(. and
vitamin B,7. on the risk of cervical dvsplasia.
Other than diet, we have also explored ses eral genetic hypotheses
regarding the etiology of cervical dvsplasia. Most recently, we
examined the risk associated with a polymorphism in the
niethylenetetrahvdrofolate reductase (MTHFR) gene. A common
variant of MTHFR. which catalyzes the synthesis of 5-
niethltetrahydrofolate, results from a 677C6T lalaóval) substitu
tion in the gene. This variant has been shown to have reduced
enzvmaticac tivitv and is associated with nit Id
hvperhomoc\ steinenlia. We found a positive. monotonic trend (p =
0.02 tin the risk ofccrvical SIL associated vs ith the numberofyariant
tITHER Talleles. Women vs ith the heterozvgous Ci genotype had
tss ice the risk ofcerv ical SIL. and women with the homozygous Ti
genotype had almost three times the risk of SIL, compared to women
who were homozygous for the wild type (CC) MTHFR genotype.
Tobacco smoking has been associated with the risk of cervical
malignancy and SIL. and nmcottne. cotinine. and tobacco—specific
nitrosamincs have been detected ti the cervical mucus ot’ smokers.
Although the significance of these obsers ations is unclear. D\ A
addncts ot bulks aromatic compounds have been found vs ith in
creased frequency in the cers ical epithelium of smokers compared
to mis snsmokers,’ pt’oviding biochemical evidence that smoking rna
he a cause of cervical cancer. Based on the significant positive
association of tobacco smoking and cervical dysplasia in this inves
tigation. we explored the hypothesis that cenetic polymorphisms in
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the cytochrome P450 I A I CYPIA I and glutaihione S-iransferase
classes mu and theta (GSTMJ and GSTTI) genes promote dyspiastic
change by moderating the activation and detoxification of polycy
die hydrocarbons and other compounds that influence oxidative
stress and DNA adduct formation. \\omcn who v crc homozvgous.
but not heteroz sons. for the CYPL-l I Msp! variant allele were at
significantly increasedrisk of cervical SiLcompared to women
were homozygous for the wild—t pe allele; Subjects ssith the
GSTMI null genotype were also at (borderline) elevated risk of
cervical SIL compared to women with the gene present. No differ
ence in the risk of cervical disease w as associated with the GSTTI
variant eenotvpe. The combination of the C)PI- I homotous
variant and the (i.STMI nut genotpes increased the odds ratio for
cervical SIL to 5.1 (95 confidence interval: 1.3-20.8). Ii is possible
that both the C 1PIA I MspJ and GST1I I polymorphisms are suscep
tibility factors for early, premalignant changes in the cervical
epithet ium.
The recognition that I-IPV infection may he a necessar cause of
cervical cancer has mayor impact on the epidemiolosical studs
of this disease. Of critical scientific and public health importance is
whether the presently established risk factors for cervical d splasia.
such as tobacco smoking. are HPV cofactors that modify the
progression of HPV infection to cancer or are simply correlated with
viral infection. In collaboration with several local health care
providers, we are presently engaged in another National Cancer
Institute—funded project to establish a multiethnic cohort of 1,150
HPV-positive women for long—term folloss -up to identifs factors
that intl uence the persistence or resolution of F{PV infection of the
cervix. The project aims are I ) to study the association of the dietary
intake of fruits and vegetables and the plasma levels of carotenoids.
tocopherols, and vitamin C with HPV persistence. and 2) to examine
the role of HPV type, viral quantirs . and multiple HPV infections in
HPV persistence. The identification of these factors mas provide
insight into the natural history of HPV infection and ma impros e
the ability to characterize women who are at greatest risk for
developing HPV-associated neoplasia. A unique feature of this
investigation is the development of a laboratory capability at the
Cancer Research Center to perform HPV-testing. This is the only
such laboratory in Hawaii and has been used increasingls by local
physicians.
At present. we have enrolled over 1.000 local women of whom
210 svere HPV-positive on the first or subsequent visits. We are
asking for your help in enrolling additional volunteers. Participants
in the study will he monitored through quarterl\ screening during a
.3 follow—up period. At each visit, a Pap smear is obtained, alone
with a blood specimen and collection of cer’ ical cells for 1-IPV
testing. All participants ss ill be reimbursed for their tIme and travel.
Women at least I 8 years old, not curiently pregnant, and who has e
no prior history of hysterectomy are eligible for the stud Call Dr.
Brenda I-fernandez at (808)586-2987 for more information about
participation in this study.
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To order an information packet on Pap tests
containing newly revised Pap test materials,
:all the NCI’s Cancer Information Service
at 1-800-4-CANCER (1 -800-422-6237).
Persons with T’fY equipment, dial
1 -800-332-8615,
‘Osit NCfa Web cur at www.cancer.gov
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